Adding Gemcitabine to First-Line Treatment Regimen Increases Efficacy in ... Monthly Prescribing Reference SAN DIEGO, CA—A first-line regimen that incorporated gemcitabine with rituximab, cyclophosphamide, vincristine, and prednisolone (R-GCVP) for the treatment of patients with diffuse large B-cell lymphoma (DLBCL) ineligible for anthracycline-containing ... |
